Skip navigation

News & Events

Keep up to date on AgNovos events and related news

Archive - 2021

AgNovos Healthcare to Co-sponsor ESCEO-AgNovos Young Investigator Awards at World Congress on Osteoporosis

AgNovos will once again co-sponsor the ESCEO-AgNovos Young Investigator Awards at this year’s virtual World Congress on Osteoporosis from August 26-29th.

AgNovos Healthcare to Participate in World Congress on Osteoporosis

AgNovos Healthcare will participate in this year’s virtual World Congress on Osteoporosis from August 26-29.

AGN1 LOEP SV Kit Receives an Investigational Device Exemption (IDE) from the U.S. FDA

AgNovos Healthcare, a developer of medical technology products leveraging regenerative medicine to treat the local effects of bone disease, announced today that its newest investigational product, AGN1 Local Osteo-enhancement Procedure (LOEP) Small Volume (SV) kit has received an Investigational Device Exemption (IDE) from the U.S. Food and Drug Administration.